MRI-detected extramural vascular invasion potentiates the risk for pathological metastasis to the lateral lymph nodes in rectal cancer

被引:0
作者
Atsushi Hamabe
Masayuki Ishii
Koichi Onodera
Kenji Okita
Toshihiko Nishidate
Koichi Okuya
Emi Akizuki
Ryo Miura
Takahiro Korai
Masamitsu Hatakenaka
Ichiro Takemasa
机构
[1] Sapporo Medical University,Department of Surgery, Surgical Oncology and Science
[2] Sapporo Medical University,Department of Diagnostic Radiology
来源
Surgery Today | 2021年 / 51卷
关键词
Rectal cancer; Lateral lymph node; Lateral lymph node dissection; Extramural vascular invasion; Magnetic resonance imaging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1583 / 1593
页数:10
相关论文
共 254 条
[1]  
Heald RJ(1986)Recurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1479-1482
[2]  
Ryall RD(1994)Role of circumferential margin involvement in the local recurrence of rectal cancer Lancet 344 707-711
[3]  
Adam IJ(2006)Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114-1123
[4]  
Mohamdee MO(2001)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638-646
[5]  
Martin IG(2006)Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620-4625
[6]  
Scott N(2012)Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933
[7]  
Finan PJ(1995)Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer Eur J Cancer 31A 1229-1232
[8]  
Johnston D(2006)Indication and benefit of pelvic sidewall dissection for rectal cancer Dis Colon Rectum 49 1663-1672
[9]  
Bosset JF(2020)Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer Int J Clin Oncol 25 1-42
[10]  
Collette L(2017)Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, Noninferiority Trial Ann Surg 266 201-207